Walid K Salah, Matthew C Findlay, Cordell M Baker, Jonathan P Scoville, Michael Bounajem, Christopher Ogilvy, Justin Moore, Howard Riina, Elad I Levy, Adnan H Siddiqui, Alejandro Spiotta, C Michael Cawley, Alexander Khalessi, Omar Tanweer, Ricardo Hanel, Bradley Gross, Okkes Kuybu, Brian M Howard, Alex N Hoang, Ammad A Baig, MirHojjat Khorasanizadeh, Aldo A Mendez Ruiz, Gustavo Cortez, Jason M Davies, Mike Lang, Ajith J Thomas, Daniel Tonetti, Jane Khalife, Georgios S Sioutas, Kate Carroll, Zachary A Abecassis, Brian Jankowitz, Juan Francisco Ruiz Rodriguez, MIchael Levitt, Peter Kan, Jan Karl Burkhardt, Visish Srinivasan, Mohamed M Salem, Ramesh Grandhi
Middle meningeal artery embolization (MMAE) is emerging as a safe and effective standalone intervention for nonacute subdural hematomas (NASHs); however, the risk of hematoma recurrence after MMAE in coagulopathic patients is unclear. To characterize the impact of coagulopathy on treatment outcomes, we analyzed a multi-institutional database of patients who underwent standalone MMAE as treatment of NASH. We classified 537 patients who underwent MMAE as a standalone intervention between 2019 and 2023 by coagulopathy status...
March 13, 2024: Journal of Neurotrauma